Kerr D I, Ong J, Doolette D J, Schafer K, Prager R H
Department of Anaesthesia and Intensive Care, The University of Adelaide, Adelaide, South Australia 5005, Australia.
Eur J Pharmacol. 1995 Dec 12;287(2):185-9. doi: 10.1016/0014-2999(95)00641-9.
In the guinea-pig isolated ileum, (RS)-(+/-)-baclofen induced a depression of cholinergic twitch contractions, reversibly and competitively antagonised by (S)-2-hydroxysaclofen (pA2 = 5.2 +/- 0.2), but not by (R)-2-hyroxysaclofen. The depression of excitatory field potentials by baclofen ( 5 mu M) in rat CA1 hippocampal slices was antagonised by (S)-2-hydroxysaclofen (100 mu m) (pA2 = 4.3), whilst in rat neocortex, (S)-2-hyroxysaclofen (50-500 mu M) antagonised the baclofen (10 mu M)-induced suppression of spontaneous discharges, the (R)-enantiomer being inactive. These results show that (S)-2-hydroxysaclofen is the active antagonist at central and peripheral GABAB receptors.
在豚鼠离体回肠中,(RS)-(±)-巴氯芬可引起胆碱能抽搐收缩的抑制,(S)-2-羟基巴氯芬可对其产生可逆性竞争性拮抗作用(pA2 = 5.2±0.2),而(R)-2-羟基巴氯芬则无此作用。在大鼠CA1海马切片中,巴氯芬(5μM)引起的兴奋性场电位抑制可被(S)-2-羟基巴氯芬(100μM)拮抗(pA2 = 4.3),而在大鼠新皮层中,(S)-2-羟基巴氯芬(50 - 500μM)可拮抗巴氯芬(10μM)引起的自发放电抑制,(R)-对映体则无活性。这些结果表明,(S)-2-羟基巴氯芬是中枢和外周GABAB受体的活性拮抗剂。